Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints

MLA

Ming Yuan Hong, et al. “Empirical Third-Generation Cephalosporin Therapy for Adults with Community-Onset Enterobacteriaceae Bacteraemia: Impact of Revised CLSI Breakpoints.” International Journal of Antimicrobial Agents, vol. 47, Apr. 2016, pp. 297–303. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2016.01.010.

APA

Ming Yuan Hong, Ming Chi Li, Ching Chi Lee, Chih Hsien Chi, Chih Chia Hsieh, & Chung Hsun Lee. (2016). Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints. International Journal of Antimicrobial Agents, 47, 297–303. https://doi.org/10.1016/j.ijantimicag.2016.01.010

Chicago

Ming Yuan Hong, Ming Chi Li, Ching Chi Lee, Chih Hsien Chi, Chih Chia Hsieh, and Chung Hsun Lee. 2016. “Empirical Third-Generation Cephalosporin Therapy for Adults with Community-Onset Enterobacteriaceae Bacteraemia: Impact of Revised CLSI Breakpoints.” International Journal of Antimicrobial Agents 47 (April): 297–303. doi:10.1016/j.ijantimicag.2016.01.010.